<DOC>
	<DOCNO>NCT01818115</DOCNO>
	<brief_summary>The objective study demonstrate ability Hydrus Implant low intraocular pressure glaucoma patient undergo cataract surgery .</brief_summary>
	<brief_title>Safety Efficacy Trial Evaluate Hydrus ( TM ) Implant Subjects Undergoing Cataract Surgery .</brief_title>
	<detailed_description>This post-market , prospective , single-masked , randomize , control , multicenter clinical trial compare Cataract Extraction ( CE ) surgery + Hydrus Implant v CE surgery alone reduction intraocular pressure ( IOP ) patient positive diagnosis open angle glaucoma ( POAG ) pseudoexfoliative glaucoma . Eligible patient schedule cataract surgery . At time procedure , qualified subject randomize 1 2 treatment group : Hydrus Implant cataract surgery cataract surgery alone . Post-operative follow conduct regular interval .</detailed_description>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Cataract</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<criteria>Diagnosis Primary Open Angle Glaucoma Pseudoexfoliative Glaucoma . Operable , agerelated cataract eligible phacoemulsification . Closed Angle narrow angle form Glaucoma . Other Secondary Glaucoma , ( neovascular , uveitic , traumatic , steroid induce , lens induce ) ; glaucoma associate increase episcleral venous pressure ; congenital developmental glaucoma .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>POAG</keyword>
	<keyword>PXG</keyword>
	<keyword>IOL Surgery</keyword>
	<keyword>CE Surgery</keyword>
</DOC>